Salvax Duo, which contains one unit of Salvax Foam (salicylic acid 6% foam) and one unit of Hydro 40 Foam (urea 40% foam), has been made available by Quinnova Pharmaceuticals. Salvax Foam and Hydro 40 Foam are both indicated for hyperkeratotic conditions such as dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma and dry, rough skin, as well as corns and calluses. Additionally, both Salvax Foam and Hydro 40 Foam use Quinnova’s patented Proderm Technology, a non-comedogenic, alcohol- and organic solvent-free, water-lipid based formulation that has anti-inflammatory, skin repair and protective properties.
For more information call (215) 860-6263 or visit www.quinnova.com.